Targeting the AKT/mTOR/p70S6K Pathway for Oligodendrocyte Differentiation and Myelin Regeneration in Neurological Disorders
CONCLUSION: Our findings highlight the potential of targeting the AKT/mTOR/p70S6K pathway in promoting oligodendrocyte differentiation and myelin regeneration in neurological disorders such as SCI.PMID:37817523 | DOI:10.2174/0115672026274954230919070115 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - October 11, 2023 Category: Neurology Authors: Chen Ge Changwei Li Source Type: research
Targeting the AKT/mTOR/p70S6K Pathway for Oligodendrocyte Differentiation and Myelin Regeneration in Neurological Disorders
CONCLUSION: Our findings highlight the potential of targeting the AKT/mTOR/p70S6K pathway in promoting oligodendrocyte differentiation and myelin regeneration in neurological disorders such as SCI.PMID:37817523 | DOI:10.2174/0115672026274954230919070115 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - October 11, 2023 Category: Neurology Authors: Chen Ge Changwei Li Source Type: research
Targeting the AKT/mTOR/p70S6K Pathway for Oligodendrocyte Differentiation and Myelin Regeneration in Neurological Disorders
CONCLUSION: Our findings highlight the potential of targeting the AKT/mTOR/p70S6K pathway in promoting oligodendrocyte differentiation and myelin regeneration in neurological disorders such as SCI.PMID:37817523 | DOI:10.2174/0115672026274954230919070115 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - October 11, 2023 Category: Neurology Authors: Chen Ge Changwei Li Source Type: research
Targeting the AKT/mTOR/p70S6K Pathway for Oligodendrocyte Differentiation and Myelin Regeneration in Neurological Disorders
CONCLUSION: Our findings highlight the potential of targeting the AKT/mTOR/p70S6K pathway in promoting oligodendrocyte differentiation and myelin regeneration in neurological disorders such as SCI.PMID:37817523 | DOI:10.2174/0115672026274954230919070115 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - October 11, 2023 Category: Neurology Authors: Chen Ge Changwei Li Source Type: research
Targeting the AKT/mTOR/p70S6K Pathway for Oligodendrocyte Differentiation and Myelin Regeneration in Neurological Disorders
CONCLUSION: Our findings highlight the potential of targeting the AKT/mTOR/p70S6K pathway in promoting oligodendrocyte differentiation and myelin regeneration in neurological disorders such as SCI.PMID:37817523 | DOI:10.2174/0115672026274954230919070115 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - October 11, 2023 Category: Neurology Authors: Chen Ge Changwei Li Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs)
Curr Neurovasc Res. 2023 Sep 28. doi: 10.2174/1567202620999230928124725. Online ahead of print.NO ABSTRACTPMID:37767959 | DOI:10.2174/1567202620999230928124725 (Source: Current Neurovascular Research)
Source: Current Neurovascular Research - September 28, 2023 Category: Neurology Authors: Kenneth Maiese Source Type: research
